title: [Expert testimony re phosphodiesterase 5 inhibitors].
authors.affiliation: Chirurgischen Klinik und Poliklinik Würzburg I (ZOM), Oberdürrbacherstr. 6 97080, Würzburg.
authors.forename: A
authors.initials: A
authors.lastname: Thiede
authors.forename: Hans-Joachim
authors.initials: HJ
authors.lastname: Zimmermann
mesh_terms: D003142:Communication; D000075202:Contraindications; D005104:Expert Testimony; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage / Q000009:adverse effects*; D008297:Male; D008318:Malpractice; D058986:Phosphodiesterase 5 Inhibitors; D010726:Phosphodiesterase Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D010817:Physician-Patient Relations; D010879:Piperazines / Q000008:administration & dosage / Q000009:adverse effects*; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000201:enzymology* / Q000601:surgery; D013450:Sulfones / Q000008:administration & dosage / Q000009:adverse effects; D014227:Triazines / Q000008:administration & dosage / Q000009:adverse effects; D000069058:Vardenafil Dihydrochloride; D014786:Vision Disorders / Q000139:chemically induced
chemical_list: D007093:Imidazoles; D058986:Phosphodiesterase 5 Inhibitors; D010726:Phosphodiesterase Inhibitors; D010879:Piperazines; D013450:Sulfones; D014227:Triazines; D000069058:Vardenafil Dihydrochloride